SHP Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

SHP Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.56K	Hold	92	–	–	﹤0.01%	909
2025 Q4	$9.49K	Buy	+92	New	+$8.95K	﹤0.01%	846

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

SHP Wealth Management's PPH Position: Q1 2026 in Review

SHP Wealth Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 92 shares worth $9.56K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

SHP Wealth Management first reported a position in PPH in Q4 2025 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

SHP Wealth Management held 92 shares of VanEck Pharmaceutical ETF worth $9.56K as of Q1 2026.
SHP Wealth Management left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #909 holding.
SHP Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 2 quarters since.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.